We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance

Read time: Less than a minute

The eSensor Respiratory Viral Panel is designed to be a fast, easy-to-use molecular diagnostic test to provide accurate results while requiring less technologist time.

"The submission to the FDA of our eSensor Respiratory Viral Panel is an important step in GenMark's continued commitment to providing our customers with high quality in-vitro diagnostic molecular tests for use with our award winning eSensor XT-8 system," commented Hany Massarany, President and CEO of GenMark Diagnostics.